Company Filing History:
1 out of 3,221 
1 out of 39 
Years Active: 2021
Title: Ryan J Hartmaier: Innovator in Cancer Diagnosis and Treatment
Introduction
Ryan J Hartmaier is a notable inventor based in Cambridge, MA (US). He has made significant contributions to the field of cancer research, particularly in the diagnosis and treatment of cancer through innovative methods.
Latest Patents
Hartmaier holds a patent for "Methods for diagnosing and treating cancer by means of the expression status and mutational status of NRF2 and downstream target genes." This invention provides methods for identifying subjects with cancer, such as lung cancer, by analyzing the expression levels of one or more NRF2 splice variants or NRF2 target genes. Additionally, it offers methods for treating cancer in subjects with a NRF2 pathway antagonist, specifically targeting those who express one or more NRF2 splice variants or overexpress NRF2 target genes. He has 1 patent to his name.
Career Highlights
Throughout his career, Hartmaier has worked with prominent companies in the biotechnology sector, including Genentech, Inc. and Foundation Medicine, Inc. His work has been instrumental in advancing cancer treatment methodologies.
Collaborations
Hartmaier has collaborated with esteemed colleagues such as Christiaan Nicolaas Klijn and James M Lee, contributing to the collective effort in cancer research and innovation.
Conclusion
Ryan J Hartmaier's innovative work in cancer diagnosis and treatment exemplifies the impact of research and development in the medical field. His contributions continue to pave the way for advancements in cancer therapies.